Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis.
Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S. Wolf AS, et al. Among authors: nygaard go. JCI Insight. 2023 Jun 22;8(12):e165111. doi: 10.1172/jci.insight.165111. JCI Insight. 2023. PMID: 37159281 Free PMC article.
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A. Riise J, et al. Among authors: nygaard go. Br J Haematol. 2022 Jun;197(6):697-708. doi: 10.1111/bjh.18149. Epub 2022 Mar 21. Br J Haematol. 2022. PMID: 35254660 Free PMC article.
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.
König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO. König M, et al. Among authors: nygaard go. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):19-22. doi: 10.1136/jnnp-2021-327612. Epub 2021 Oct 20. J Neurol Neurosurg Psychiatry. 2023. PMID: 34670844 Free PMC article.
[Correction: Disease-modifying therapy for multiple sclerosis].
Holmøy T, Nygaard GO, Myhr KM, Bø L. Holmøy T, et al. Among authors: nygaard go. Tidsskr Nor Laegeforen. 2021 Jun 10;141(10). doi: 10.4045/tidsskr.21.0454. Print 2021 Jun 29. Tidsskr Nor Laegeforen. 2021. PMID: 34182741 Free article. Norwegian. No abstract available.
Disease-modifying therapy for multiple sclerosis.
Holmøy T, Nygaard GO, Myhr KM, Bø L. Holmøy T, et al. Among authors: nygaard go. Tidsskr Nor Laegeforen. 2021 May 10;141(8). doi: 10.4045/tidsskr.21.0155. Print 2021 May 25. Tidsskr Nor Laegeforen. 2021. PMID: 34047171 Free article. English, Norwegian.
28 results